Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Leukemia Lymphocytic Chronic B-Cell”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)Looking for participantsNCT06651970
What this trial is testing

Acalabrutinib Monotherapy vs Investigator's Choice of Treatment in Patients With CL Leukaemia and Heart Failure

Who this might be right for
Chronic Lymphocytic LeukaemiaModerate to Severe Cardiac Impairment
AstraZeneca 60
Testing effectiveness (Phase 2)WithdrawnNCT00485966
What this trial is testing

Study Evaluating Effects of CX-3543 in Patients With Relapsed or Refractory B-Cell Chronic Lymphocytic Leukemia

Who this might be right for
B-Cell Chronic Lymphocytic Leukemia
Cylene Pharmaceuticals 25
Testing effectiveness (Phase 2)Study completedNCT00026351
What this trial is testing

Pentostatin and Rituximab in Treating Patients With Low-Grade Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia

Who this might be right for
LeukemiaLymphoma
Pharmatech Oncology
Testing effectiveness (Phase 2)Ended earlyNCT03333486
What this trial is testing

Fludarabine Phosphate, Cyclophosphamide, Total Body Irradiation, and Donor Stem Cell Transplant in Treating Patients With Blood Cancer

Who this might be right for
Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 PositiveAcute Leukemia in RemissionAcute Lymphoblastic Leukemia+34 more
Roswell Park Cancer Institute 31
Post-approval studies (Phase 4)Study completedNCT00802737
What this trial is testing

Efficacy and Safety of Ofatumumab Retreatment and Maintenance Treatment in Patients With B-cell Chronic Lymphocytic Leukemia (CLL)

Who this might be right for
Leukaemia, Lymphocytic, Chronic
GlaxoSmithKline 29
Testing effectiveness (Phase 2)Study completedNCT00079391
What this trial is testing

Stem Cell Transplantation and T-Cell Add-Back to Treat Bone Marrow Malignancies

Who this might be right for
Hematologic MalignanciesBone Marrow Transplant Rejection
National Heart, Lung, and Blood Institute (NHLBI) 50
Early research (Phase 1)Active Not RecruitingNCT04629729
What this trial is testing

FT819 in Subjects With B-cell Malignancies

Who this might be right for
Lymphoma, B-CellChronic Lymphocytic LeukemiaPrecursor B-Cell Acute Lymphoblastic Leukemia
Fate Therapeutics 54
Early research (Phase 1)UnknownNCT03685786
What this trial is testing

CART19 Cells Treatment of MRD of B Cell Malignancies and Then Auto-HSCT

Who this might be right for
Leukemia, Lymphocytic, Acute, B-CellLeukemia, Lymphocytic, Chronic, B-CellLymphoma, B-Cell
Shenzhen Second People's Hospital 20
Early research (Phase 1)Study completedNCT02128945
What this trial is testing

Dosimetry and Biodistribution of [18F]-Fludarabine in Lymphoid Malignancies

Who this might be right for
Untreated B-Chronic Lymphocytic Leukemia or Diffuse Large B Cells Lymphoma Patients
University Hospital, Caen 10
Testing effectiveness (Phase 2)WithdrawnNCT04660045
What this trial is testing

Early Intervention With Acalabrutinib in Patients With High Risk CLL

Who this might be right for
Chronic Lymphocytic LeukemiaCLL/SLL
Weill Medical College of Cornell University
Testing effectiveness (Phase 2)Study completedNCT00558675
What this trial is testing

A Phase I/II Study of Mis-Matched Immune Cells (AlloStim) in Patients With Advanced Hematological Malignancy

Who this might be right for
Hematological MalignancyLeukemiaLymphoma+1 more
Mirror Biologics, Inc. 6
Testing effectiveness (Phase 2)Looking for participantsNCT05281809
What this trial is testing

Local Manufacture of CAR T-Cell Products for the Treatment of B-Cell Lymphoma and B-Acute Lymphoblastic Leukemia

Who this might be right for
B-Cell LymphomaB Acute Lymphoblastic LeukemiaDiffuse Large B Cell Lymphoma+6 more
John Lister 30
Large-scale testing (Phase 3)Study completedNCT01578707
What this trial is testing

Ibrutinib (PCI-32765) Versus Ofatumumab in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia

Who this might be right for
Relapsed or Refractory Chronic Lymphocytic LeukemiaSmall Lymphocytic Lymphoma
Pharmacyclics LLC. 391
Testing effectiveness (Phase 2)UnknownNCT02007811
What this trial is testing

Open-label Clinical Trial to Investigate the Safety and Tolerability of Allogeneic B-cell Concentrates for Immune Reconstitution After Allogeneic Stem Cell Transplantation Measured as Response to a Antedated Single Vaccination

Who this might be right for
Acute Myeloid LeukemiaAcute Lymphoblastic LeukemiaChronic Myeloid Leukemia+5 more
University of Erlangen-Nürnberg Medical School 15
Not applicableEnrolling By InvitationNCT02473757
What this trial is testing

Gene Therapy Follow-up Protocol for People Previously Enrolled in CAR-T Cell Studies

Who this might be right for
Lyphoma, B-CellLeukemia, B-cellMultiple Myeloma+1 more
National Cancer Institute (NCI) 1,000
Early research (Phase 1)Study completedNCT04210219
What this trial is testing

JNJ-64264681 in Participants With Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia

Who this might be right for
Lymphoma, Non-HodgkinLeukemia, Lymphocytic, Chronic, B-Cell
Janssen Research & Development, LLC 85
Early research (Phase 1)Active Not RecruitingNCT05688475
What this trial is testing

A Rollover Study of CC-122

Who this might be right for
Non-Hodgkin Lymphoma
Bristol-Myers Squibb 12
Testing effectiveness (Phase 2)Looking for participantsNCT05694312
What this trial is testing

Ibrutinib for the Treatment of AIHA in Patients With CLL/SLL or CLL-like MBL

Who this might be right for
Autoimmune Hemolytic AnemiaChronic Lymphocytic LeukemiaSmall Lymphocytic Lymphoma+1 more
Gruppo Italiano Malattie EMatologiche dell'Adulto 45
Not applicableEnded earlyNCT03436771
What this trial is testing

Long-term Follow-up Study for Patients Previously Treated With a Juno CAR T-Cell Product

Who this might be right for
Non Hodgkin LymphomaMultiple MyelomaChronic Lymphocytic Leukemia+3 more
Juno Therapeutics, a Subsidiary of Celgene 4
Testing effectiveness (Phase 2)Study completedNCT00378534
What this trial is testing

Methods to Enhance the Safety and Effectiveness of Stem Cell Transplants

Who this might be right for
Chronic Myelogenous LeukemiaAcute Myelogenous LeukemiaChronic Lymphocytic Leukemia+2 more
National Heart, Lung, and Blood Institute (NHLBI) 116
Next Page